+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

From
From
From
From
From
Mucinous cystic neoplasms (MCNs) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Mucinous cystic neoplasms (MCNs) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Pancreatic Endocrine Tumor - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pancreatic Endocrine Tumor - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020 - Product Thumbnail Image

US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020

  • Report
  • September 2019
  • 177 Pages
  • United States, Europe United States, Europe
From
From
From
From
From
From
Market Spotlight: Small-Cell Lung Cancer (SCLC) - Product Thumbnail Image

Market Spotlight: Small-Cell Lung Cancer (SCLC)

  • Report
  • November 2020
  • 49 Pages
  • Global
Market Spotlight: Esophageal Cancer (2020) - Product Thumbnail Image

Market Spotlight: Esophageal Cancer (2020)

  • Report
  • March 2020
  • 42 Pages
  • Global
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more